Skip to main content
Premium Trial:

Request an Annual Quote

Cytena Inks China Distribution Deal for Single-Cell Isolators

NEW YORK — Cytena said on Tuesday that it has signed a two-year agreement to supply single-cell isolators to Applitech Pharmaceutical Equipment Technology for distribution in China.

Under the terms of the deal, Cytena will receive about $10 million in exchange for providing Guangzhou-based Applitech with nearly 100 of the devices, which include its Up Sight instrument, with the potential for additional sales in the future.

“Cytena's single-cell isolators have helped researchers across the world advance cell line development research," Jonas Schöndube, business area director for biosciences at Cytena parent firm Bico, said in a statement. "We're thrilled to expand our footprint in China and help drive innovation across gene therapies, biosimilars, and monoclonal antibodies."

Freiburg, Germany-based Cytena was acquired in 2019 by Cellink, which rebranded as Bico earlier this year.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.